POLL: High Support for Medical Marijuana around the United States
High Support for Medical Marijuana ABC News/Washington Post Poll: 81 Percent Support Legalizing Marijuana for Medical Use Credit: Getty Images
Eight in 10 Americans support legalizing marijuana for medical use and nearly half favor decriminalizing the drug more generally, both far higher than a decade ago.
With New Jersey this week poised to become the 14th state to legalize medical marijuana, 81 percent in this national ABC News/Washington Post poll support the idea, up from an already substantial 69 percent in 1997. Indeed the main complaint is with restrictions on access, as in the New Jersey law.
Fifty-six percent say that if it's allowed, doctors should be able to prescribe medical marijuana to anyone they think it can help. New Jersey's measure, which is more restrictive than most, limits prescriptions to people with severe illnesses. State health officials can add to the list.
DECRIMINALIZE? – Apart from medical marijuana, there have been recent efforts to decriminalize marijuana more broadly in some states. A preliminary vote on one such measure is to be held in the Washington state Legislature this week. In California organizers say they've collected enough signatures to hold a statewide referendum on the issue next fall. And a separate proposal in California to legalize and tax the drug cleared a legislative committee last week. A Field poll there in April found 56 percent support for the idea, which its backers say would raise $1.3 billion a year.
Continue reading these facts...
Top 10 Cannabis Studies the Government Wished it Had Never Funded
Yes, that's right.....Government funded studies have reached conclusions that marijuana prevents cancer, the gateway effect is a myth, and has no increased risk of lung cancer.
Can't really claim bias for this one....
10) MARIJUANA USE HAS NO EFFECT ON MORTALITY:
A massive study of California HMO members funded by the National Institute on Drug Abuse (NIDA) found marijuana use caused no significant increase in mortality. Tobacco use was associated with increased risk of death.
A Big Week for Marijuana Legalization
The California Assembly's public safety committee voted 4-3 yesterday in favor of a bill that would legalize marijuana and regulate it like alcohol. Although the bill likely won't go anywhere (it will miss a deadline to reach the full floor for a vote), this is the first time a statewide committee has approved such a measure and it's a sure sign that attitudes are changing in California and across the country.
The news came a day after New Jersey became the 14th state to approve marijuana for medicinal use. Gov. Jon Corzine says he'll sign the bill into law before he leaves office this week.
The momentum toward marijuana legalization continues to grow. On Monday, activists filed a petition in Washington state that will put full legalization on the ballot before voters in November.
A poll this week in California found 84 percent of the state in favor of legalizing marijuana, and a study conducted by the legislature found that taxing marijuana $50 an ounce would raise about $1 billion for the state.
Marijuana Compounds Could Beat Back Brain Cancer
Preliminary research suggests that a combination of compounds in marijuana could help fight off a particularly deadly form of brain cancer.
But the findings shouldn't send patients rushing to buy pot: the levels used in the research appear to be too high to obtain through smoking. And there's no sign yet that the approach works in laboratory animals, let alone people.
Still, the finding does suggest that more than one compound in marijuana might boost cancer treatment, said study author Sean McAllister, an associate scientist at California Pacific Medical Center Research Institute in San Francisco. "Combination therapies might be more appropriate," McAllister said.
Researchers have long studied the compounds in marijuana known as cannabinoids, which are thought to hold possible health benefits. One, known as THC, is well known for its role in making people high when they smoke or eat pot. Researchers have been testing it as a treatment for the brain tumors known as glioblastomas.
The economics of drugs: marijuana, cocaine, meth – supply vs demand is twisted!
Now that's a nice cloud of marijuana smoke. Credit: Pam Templeton
The Government Action Plan on Methamphetamine is working by at least one measure – price. A gram of P, according to one Auckland drug dealer, now costs around $800, whereas a year ago the same amount set users back about $300-$400.
The doubling in price tells a supply side-story. Prime Minister John Key launched the plan in early October and, among other measures designed to restrict supply, made the important precursor drug, pseudoephedrine, prescription-only.
Also, in the two months to early December, Customs intercepted a total of 230kg of pseudoephedrine at the border. When commodities become scarce, consumer demand drives the price up.
The government is, says Key, winning "the fight against P".
But if "we" are winning the fight, what will success entail? An exhaustive account of the global cocaine trade (The Candy Machine, How Cocaine Took Over the World, by Tom Feiling) suggests all of the efforts by government and its agencies will make not a jot of difference and may even generate a worse social outcome.
NORML Director: Amazing 2009! Awesome 2010 Ahead!
Dear NORML Supporter: It is not often that I feel compelled to write to NORML’s membership and supporters regarding the day-to-day operations of America’s leading marijuana lobby group. Then again, in my tenure as Executive Director of NORML and the NORML Foundation, there’s never been a time like right now.
Over the past several months NORML’s public prominence and political influence has grown by leaps and bounds. As I write you today I’m reflecting upon two of the most significant – and productive – weeks in NORML history. As we close the year 2009 I am proud to say that NORML has galvanized its position as the leading marijuana law reform organization. Why do I say this? Take a look at the events of these two weeks late this fall, and decide for yourself.
Cannabis by product helps reduce effects of Parkinson disease medication
Brazilian researchers have tested the positive effects of canabiodiol
Six patients with Parkinson were given during a whole month small doses of "canabiodiol" one of the 400 substances in marijuana, following which encouraging results were confirmed according to scientists from the Riberao Preto Medicine School from the SP University.
"Patients with Parkinson developed improvements in their sleeping alterations, in their psychotic symptoms and could even reduce their trembling" said psychiatrist Jose Alexander Crippa, Neuro-sciences Department professor.
The paper on the discovery was published last November and next year an additional paper with test results on the anxiolytic effects of "canabiodiol" in patients with obsession and compulsion disorders will be released.
Mainstream Media Botches Marijuana Stories
For anyone who missed the worldwide corporate media’s hysterical anti-pot headlines last week, here’s a sampling:
Cannabis more damaging to adolescent brains than previously known
via Emax Health
“New research shows that teens who consume cannabis daily can suffer anxiety and depression. Smoking marijuana can have long-term irreversible effects on adolescent brains, and is more harmful to teens than previously known.”
Teen marijuana use affects brain permanently: study
via CBC News
“The findings suggest daily marijuana use by teens can cause depression and anxiety, and have an irreversible effect on the brain.”
Pot damage on teens worse than thought
via UPI wire services
“Daily consumption of marijuana in teens can cause depression and anxiety, and have irreversible long-term effect on the brain, Canadian researchers say.”
Nurses and doctors support compassionate cannabis use in Wisconsin
Madison: At the Dec. 15 combined committee (cannabis) hearing on AB554/SB368, the Jacki Rickert Medical Marijuana Act, support from health care professionals, particularly those who treat patients in real pain or represent professions that do, was strong. This was evident to those attending the hearing and to those viewing it on Wisconsin Eye.
Unfortunately, the representative of the Wisconsin State Medical Society (SMS), Dr. Michael Miller, an addiction specialist with a lucrative practice treating people involuntarily referred for counseling after detection of marijuana use, was not among those supporting the JRMMA Dec. 15.
But even Dr. Miller's on record opposition on behalf of the SMS to the Jacki Rickert Medical Marijuana Act was tempered by statements he made. As to "gateway drugs", Dr. Miller identified tobacco, a legal substance, as the number one gateway drug. He also acknowledged not only had SMS members not been polled as to whether they supported the JRMMA, but if they were, "you might get a lot of members saying yes".
Daily Pot Smoking May Hasten Onset of Psychosis
Progression to daily marijuana use in adolescence may hasten the onset of symptoms leading up to psychosis, an Emory University study finds. The study was published in the November issue of the American Journal of Psychiatry.
The researchers analyzed data from 109 hospitalized patients who were experiencing their first psychotic episode. The results showed that patients who had a history of using marijuana, or cannabis, and increased to daily pot smoking experienced both psychotic and pre-psychotic symptoms at earlier ages.
"We were surprised that it wasn't just whether or not they used cannabis in adolescence that predicted the age of onset, rather it was how quickly they progressed to becoming a daily cannabis user that was the stronger predictor," said Michael Compton, lead author and assistant professor of psychiatry in the Emory School of Medicine.
The study also found a gender difference: The female subjects who progressed to daily pot smoking had a greater increased risk for the onset of psychosis than the males.
Marijuana tough on the teenage brain possibly leading to depression or just shedding a tear
According to a Canadian researcher, the effect of heavy doses of cannabis on young brains is more severe than expected.
Dr. Gabriella Gobbi, a psychiatric researcher from the Research Institute of the McGill University Health Centre has completed a study that suggests smoking pot on a daily basis can cause depression and anxiety.
Notably, the activity can have an irreversible long-term effect on the brain.
“We wanted to know what happens in the brains of teenagers when they use cannabis and whether they are more susceptible to its neurological effects than adults,” explained Dr. Gobbi, who is also a professor at McGill University.
